Loading
Latest filing published 18 Aug 2026 for BridgeBio Pharma, Inc., €2.4M. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Only one filing by Neil Kumar is known so far (18 August 2026): a transaction, €2.4M, in BridgeBio Pharma, Inc. That is too little to draw conclusions. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration